Kalvista Pharmaceuticals, Inc. · NASDAQ:KALV
Piekos Brian sold 1,489 Kalvista Pharmaceuticals, Inc. shares (Form 4)
Traded May 21 to May 22, 2026 · Filed May 26, 2026
From May 21 to May 22, 2026, Piekos Brian (Chief Financial Officer) sold 1,489 Kalvista Pharmaceuticals, Inc. shares at US$26.78 for US$39,875, leaving 21,661 shares. Filed May 26, 2026 (Form 4).
- Sold
- 1,489 shares
- Price
- US$26.78
- Value
- US$39,875
- Holding after
- 21,661 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 21, 2026 | Common Stock | Option exercise | 5,000 | 23,150 | Direct | |
| May 22, 2026 | Common Stock | Sale | 1,489 | US$26.78 | 21,661 | Direct |
Source
Related
- Kalvista Pharmaceuticals, Inc.
- Piekos Brian
- Kalvista Pharmaceuticals, Inc. shareholders
- Form 4 · Piekos Brian · Jun 11, 2026
- Form 4 · Piekos Brian · Apr 20, 2026
- Schedule 13G/A · Tang Capital Management LLC · Aug 14, 2026
- Form 4 · Audhya Paul K. · Jun 11, 2026
- Form 4 · Sweeny Nicole · Jun 11, 2026
- Form 4 · Palleiko Benjamin L · Jun 11, 2026
- Form 4 · Yea Christopher · Jun 11, 2026